All In Biotech

Free tool

FAERS Monitor: Combivir

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020857 or its brand name (Combivir, Lamivudine, Zidovudine). Reports on generic versions are filed under their own applications.

Reports

7,705

Serious

6,925

90% of reports

Hospitalization

2,264

Death reported

595

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug exposure during pregnancy1,147
  • foetal exposure during pregnancy720
  • pain601
  • anxiety568
  • emotional distress557
  • anhedonia504
  • anaemia453
  • abortion spontaneous443
  • maternal exposure during pregnancy381
  • premature baby363
  • chronic kidney disease327
  • pyrexia285
  • stillbirth278
  • nausea270
  • osteoporosis269

Reports by year received

View as table
YearReports
2004503
2005614
2006564
2007506
2008479
2009522
2010664
2011373
2012401
2013298
2014332
2015469
2016245
2017179
2018266
2019332
2020339
2021277
2022184
202352
202449
202521
202618

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,454 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
stillbirthSignal278166.6147.942,984
drug exposure during pregnancySignal1,14795.390.2103,442
anhedoniaSignal50453.449.025,376
premature babySignal36333.330.111,225
abortion spontaneousSignal44330.527.912,499
foetal exposure during pregnancySignal72024.422.716,044
osteoporosisSignal26918.016.04,273
emotional distressSignal55712.611.65,951
chronic kidney diseaseSignal32711.810.63,218
maternal exposure during pregnancySignal38111.710.63,723
anaemiaSignal4536.55.92,115
anxietySignal5685.55.02,087
painSignal6012.72.5646
pyrexiaSignal2852.22.0200
nausea2700.90.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.